Angiotensin Blockade in Patients with Diabetic Nephropathy

View/Open
Date
2007
Format
Metadata
[+] Show full item record
Abstract
When used to delay the progression of early nephropathy in patients with type 2 diabetes mellitus, angiotensin receptor blockers (ARBs) are not superior to angiotensin-converting enzyme (ACE) inhibitors. (Strength of Recommendation: C, multiple randomized controlled trials [RCTs]).
URI
http://hdl.handle.net/10355/3984
Part of
Rights
OpenAccess.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
Collections